StemCyte International, Ltd. (TPEX:4178)
Taiwan · Delayed Price · Currency is TWD 26.70
+0.60 (2.30%)
At close: Mar 27, 2026
StemCyte International Revenue
In the year 2025, StemCyte International had annual revenue of 368.91M TWD, down -3.60%. StemCyte International had revenue of 197.31M in the half year ending June 30, 2025, with 10.24% growth.
Revenue
368.91M
Revenue Growth
-3.60%
P/S Ratio
13.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 368.91M | -13.77M | -3.60% |
| Dec 31, 2024 | 382.69M | 19.91M | 5.49% |
| Dec 31, 2023 | 362.78M | 15.09M | 4.34% |
| Dec 31, 2022 | 347.69M | -509.38M | -59.43% |
| Dec 31, 2013 | 857.07M | 124.33M | 16.97% |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wah Hong Industrial | 7.45B |
| Lih Tai Construction Enterprise | 4.18B |
| Chen Full International | 3.36B |
| Welldone Company | 3.19B |
| S-Tech | 2.59B |
| Acer Cyber Security | 2.43B |
| United Fiber Optic Communication | 1.35B |
| Best Precision Industrial | 923.35M |